Physician profile
Gregory J Roberts
NPI 1023224839
$5,010.71
in general payments reported to CMS, 2019-2025
37 companies · $712 in 2025
The $712 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $467 · 2021: $434 · 2022: $893 · 2023: $974 · 2024: $912 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,597.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $870.17 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $810.67 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $568.18 | 2019-2024 | Xarelto |
| Philips North America LLC | $431.27 | 2020-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $342.86 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $291.16 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $275.81 | 2019-2023 | |
| Pfizer INC. | $261.31 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $176.85 | 2019-2024 | Farxiga |
| Baxter Healthcare | $140.44 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Esperion Therapeutics, INC. | $83.53 | 2024-2025 | Nexletol |
| Braemar Manufacturing, LLC | $64.42 | 2019 | |
| Novo Nordisk INC | $49.86 | 2021-2023 | Ozempic |
| Amarin Pharma, INC. | $42.66 | 2020-2022 | |
| Abbott Laboratories | $41.23 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.